Cathay Biotech Inc.
SSE:688065.SS
52.2 (CNY) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| 474.589 | 366.524 | 612.655 | 646.685 | 457.341 | 478.88 | 466.293 | 332.728 | 145.47 |
| Depreciation & Amortization
| 321.158 | 285.715 | 265.122 | 168.535 | 118.317 | 116.275 | 72.618 | 46.497 | 34.73 |
| Deferred Income Tax
| 0 | -70.598 | -36.08 | -16.918 | 4.746 | -17.567 | -10.12 | -1.361 | 0 |
| Stock Based Compensation
| 0 | 0 | 16.166 | 6.236 | 0.474 | 3.247 | 0 | 4.978 | 0 |
| Change In Working Capital
| -76.75 | -233.104 | -73.881 | -212.144 | -77.961 | -226.669 | -527.77 | -361.383 | -312.498 |
| Accounts Receivables
| -246.249 | -320.055 | 24.797 | -224.955 | -32.777 | 232.28 | -453.2 | -449.638 | 0 |
| Inventory
| 198.507 | 78.298 | -418.062 | -282.619 | -90.453 | -434.027 | -343.328 | -9.731 | -162.716 |
| Accounts Payables
| 0 | 133.659 | 355.463 | 310.024 | 40.522 | -7.355 | 278.878 | 99.348 | 0 |
| Other Working Capital
| -29.008 | -125.006 | -36.08 | -14.593 | 4.746 | -17.567 | -184.442 | -351.651 | -149.782 |
| Other Non Cash Items
| 101.932 | 220.914 | 19.691 | 1.789 | 12.046 | 5.452 | -21.428 | 35.604 | 3.626 |
| Operating Cash Flow
| 820.929 | 569.451 | 803.674 | 594.183 | 514.964 | 359.618 | -10.287 | 53.446 | -128.672 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -843.313 | -1,569.781 | -4,198.356 | -1,474.675 | -763.113 | -511.14 | -410.085 | -995.091 | -323.344 |
| Acquisitions Net
| 0 | 0 | 6.14 | 1,850 | 1,100 | 2.512 | 1.51 | 995.257 | 0 |
| Purchases Of Investments
| 0 | -101.044 | 0 | -1,850 | -5,877 | -10 | -37.3 | -13.44 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 28.421 | 35.881 | 4.81 | 4.594 | 7.851 | 27.743 |
| Other Investing Activites
| 20.252 | 112.015 | -6 | 1,320 | 4,307 | -692.908 | -146.321 | -995.091 | 400.04 |
| Investing Cash Flow
| -823.061 | -1,558.81 | -4,198.216 | -126.254 | -1,197.232 | -1,206.725 | -587.602 | -1,000.514 | 104.44 |
| Financing Activities: | |||||||||
| Debt Repayment
| 122.813 | 647.254 | 386.47 | 743.08 | -300.245 | 171.769 | 50.923 | 77.4 | 0 |
| Common Stock Issued
| 0 | 0 | 94.67 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -31.525 | -94.67 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -140.835 | -104.786 | -187.299 | -333.346 | -3.872 | -121.34 | -178.823 | -0.095 | 0 |
| Other Financing Activities
| 167.513 | -773.103 | 224.261 | 2,577.715 | 6,367.563 | 1,000 | 874.177 | 638.088 | -68.359 |
| Financing Cash Flow
| 149.492 | -262.16 | 403.878 | 2,987.449 | 6,063.446 | 1,050.429 | 645.099 | 715.393 | -68.359 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 24.825 | 40.221 | 59.983 | -9.185 | -2.827 | -1.324 | 5.005 | -10.872 | 2.676 |
| Net Change In Cash
| 172.185 | -1,211.298 | -2,930.681 | 3,446.193 | 5,378.352 | 201.999 | 52.215 | -242.547 | -89.915 |
| Cash At End Of Period
| 5,185.965 | 5,013.78 | 6,225.077 | 9,155.758 | 5,709.564 | 331.212 | 129.214 | 76.998 | 319.545 |